Irbesartan/HCTZ fixed combinations in patients of different racial/ethnic groups with uncontrolled systolic blood pressure on monotherapy.

The IrbesartaN/hydroChlorothiazide (HCTZ) bLood pressUre reductionS In diVErse patient populations (INCLUSIVE) trial was a multicenter, prospective, open-label, single-arm study evaluating the efficacy and safety of irbesartan/HCTZ fixed combinations in patients > or = 18 years old with uncontrol...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Päätekijät: Ofili, Elizabeth O., Ferdinand, Keith C., Saunders, Elijah, Neutel, Joel M., Bakris, George L., Cushman, William C., Sowers, James R., Weber, Michael A.
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: National Medical Association 2006
Aiheet:
Research Article
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC2569215/
https://ncbi.nlm.nih.gov/pubmed/16623075
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia